Hemangiosarcoma is one of the most frequently diagnosed conditions in the breed within the Sloughi. Common indicators include sudden collapse, pale gums, and abdominal distension. Hemangiosarcoma is an aggressive malignant tumour of blood vessel cells. It most commonly affects the spleen, heart, and liver. Splenic rupture causing life-threatening internal haemorrhage is often the first sign. Prognosis is poor even with treatment. It typically becomes apparent at 8-13 years. The large frame of the Sloughi can accelerate progression in weight-bearing conditions, making early diagnosis particularly valuable. Treatment costs are estimated at £4,000-£10,000, making comprehensive pet insurance a practical consideration.
If your Sloughi is showing any of these signs, consult your veterinarian promptly.
Emergency splenectomy followed by chemotherapy (doxorubicin-based) is standard. Median survival with surgery alone is 1-2 months; with chemotherapy, 4-6 months. Immunotherapy is being investigated.
Estimated Treatment Cost
£4,000-£10,000
Costs vary by severity, location, and treatment path. Pet insurance is strongly recommended.
A diet formulation designed to support Sloughis managing Hemangiosarcoma. Formulated with high-quality protein and easily digestible ingredients.
Check Price on AmazonAs an Amazon Associate we earn from qualifying purchases.
Sloughis with Hemangiosarcoma benefit from consistent supplementation. This vet-formulated blend supports overall wellbeing and may complement prescribed treatment.
Check Price on AmazonAs an Amazon Associate we earn from qualifying purchases.
Prevalence and severity can vary significantly between breeds.